Sign in
S2777 Vedolizumab-Induced Reversible Lymphoproliferative Disorder in a Patient With Ulcerative Colitis
Abstract   Open access  Peer reviewed

S2777 Vedolizumab-Induced Reversible Lymphoproliferative Disorder in a Patient With Ulcerative Colitis

Divya Ashat and Animesh Jain
The American journal of gastroenterology, Vol.117(10S), pp.e1820-e1820
10/2022
DOI: 10.14309/01.ajg.0000867748.50546.e5
url
https://doi.org/10.14309/01.ajg.0000867748.50546.e5View
Published (Version of record) Open Access

Details

Metrics

9 Record Views